Impact of tacrolimus versus cyclosporin A on renal function during the first year after heart transplant.
Yasuyuki ShiraishiEisuke AmiyaMasaru HatanoToshiomi KatsukiChie BujoMasaki TsujiDaisuke NittaHisataka MakiJunichi IshidaYukie KagamiMiyoko EndoMitsutoshi KimuraMasahiko AndoShogo ShimadaOsamu KinoshitaMinoru OnoIssei KomuroPublished in: ESC heart failure (2020)
Irrespective of everolimus use with low-dose CNIs, our analysis using the instrumental variable method showed no differences in renal function as well as graft rejection during the first year after HTx between HTx recipients who received TAC or CsA.